Current Status of Implantable Cardioverter‐Defibrillators ( ICDs )/Cardiac Resynchronization Therapy With Defibrillators ( CRT ‐Ds) for Primary Prevention of Sudden Cardiac Death
Journal of Arrhythmia · 2026-04 · 42 (2)
DOI: 10.1002/joa3.70349 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Arrhythmia, online erschienen am 23.04.2026. Verfasst von Hisashi Yokoshiki und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine Sapporo City General Hospital Sapporo Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Among recipients of implantable cardioverter‐defibrillators (ICDs) or cardiac resynchronization therapy with defibrillators (CRT‐Ds), non‐ischemic etiology is predominant, accounting for more than 60% of cases in Japan, which is higher than that in the United States and other European countries. Despite recent concerns about primary prevention ICD/CRT‐D implantation for non‐ischemic patients with systolic heart failure in advanced guideline‐directed medical therapy (GDMT), ICD/CRT‐D therapy is likely effective in reducing the slope of the relationship between all‐cause death and sudden cardiac death. Two cohort studies in Japan have shown that the cumulative incidence of appropriate ICD/CRT‐D therapy is higher among non‐ischemic patients than ischemic patients receiving primary prevention ICD/CRT‐D implantation. Additionally, recent published cohort studies in the United States, Europe, and Japan reported a significant decrease in the risk of all‐cause death in primary prevention ICD/CRT‐D recipients compared to those without ICD/CRT‐D therapy. Notably, ICD/CRT‐D utilization in Japan is the lowest among the Group of Seven (G7) countries. Governmental acknowledgment of the value of primary prevention ICD/CRT‐D therapy, as well as educational activities for non‐cardiac electrophysiologists, are required to prevent a potential labor shortage and an excess of healthcare costs following out‐of‐hospital cardiac arrest (OHCA).
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine Sapporo City General Hospital Sapporo Japan.
- Department of Cardiovascular Medicine Caress Memorial Hospital Sapporo Japan.
- Department of Cardiovascular Medicine Hoshi General Hospital Kōriyama Japan.
- UBE Kohsan Central Hospital Ube Japan.
ORCID-Profile: Masaya Watanabe
Zitieren
APA
Yokoshiki, H., Watanabe, M., Mitsuhashi, T., & Shimizu, A. (2026). Current Status of Implantable Cardioverter‐Defibrillators ( ICDs )/Cardiac Resynchronization Therapy With Defibrillators ( CRT ‐Ds) for Primary Prevention of Sudden Cardiac Death. Journal of Arrhythmia, 42(2). https://doi.org/10.1002/joa3.70349
Vancouver
Yokoshiki H, Watanabe M, Mitsuhashi T, Shimizu A. Current Status of Implantable Cardioverter‐Defibrillators ( ICDs )/Cardiac Resynchronization Therapy With Defibrillators ( CRT ‐Ds) for Primary Prevention of Sudden Cardiac Death. Journal of Arrhythmia. 2026;42(2). doi:10.1002/joa3.70349
BibTeX
@article{Yokoshiki2026,
author = {Yokoshiki, Hisashi and Watanabe, Masaya and Mitsuhashi, Takeshi and Shimizu, Akihiko},
title = {Current Status of Implantable Cardioverter‐Defibrillators ( ICDs )/Cardiac Resynchronization Therapy With Defibrillators ( CRT ‐Ds) for Primary Prevention of Sudden Cardiac Death},
journal = {Journal of Arrhythmia},
year = {2026},
volume = {42},
number = {2},
doi = {10.1002/joa3.70349}
}
EUVIMED